CN102911868A - Microorganism culture medium and microorganism culture method - Google Patents
Microorganism culture medium and microorganism culture method Download PDFInfo
- Publication number
- CN102911868A CN102911868A CN201210369787XA CN201210369787A CN102911868A CN 102911868 A CN102911868 A CN 102911868A CN 201210369787X A CN201210369787X A CN 201210369787XA CN 201210369787 A CN201210369787 A CN 201210369787A CN 102911868 A CN102911868 A CN 102911868A
- Authority
- CN
- China
- Prior art keywords
- substratum
- salt
- acid
- culture
- preferred
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 244000005700 microbiome Species 0.000 title claims abstract description 15
- 239000001963 growth medium Substances 0.000 title abstract description 10
- 238000012136 culture method Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 claims abstract description 72
- 238000000855 fermentation Methods 0.000 claims abstract description 59
- 230000004151 fermentation Effects 0.000 claims abstract description 59
- 230000008569 process Effects 0.000 claims abstract description 34
- 239000002253 acid Substances 0.000 claims abstract description 26
- 239000012138 yeast extract Substances 0.000 claims abstract description 16
- 150000003863 ammonium salts Chemical class 0.000 claims abstract description 6
- 241000195493 Cryptophyta Species 0.000 claims description 27
- 239000000203 mixture Substances 0.000 claims description 27
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 15
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 15
- 229940041514 candida albicans extract Drugs 0.000 claims description 15
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical group [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 claims description 15
- 235000013923 monosodium glutamate Nutrition 0.000 claims description 15
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 15
- 229940073490 sodium glutamate Drugs 0.000 claims description 15
- CGIDKJRJBMFXKV-UHFFFAOYSA-N 6-n'-benzylpurine-6,6-diamine Chemical compound N1=CN=C2N=CN=C2C1(N)NCC1=CC=CC=C1 CGIDKJRJBMFXKV-UHFFFAOYSA-N 0.000 claims description 14
- 229910052799 carbon Inorganic materials 0.000 claims description 14
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 13
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 13
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 13
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 12
- 229930003756 Vitamin B7 Natural products 0.000 claims description 12
- 239000008103 glucose Substances 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- 235000011912 vitamin B7 Nutrition 0.000 claims description 12
- 239000011735 vitamin B7 Substances 0.000 claims description 12
- 230000003321 amplification Effects 0.000 claims description 11
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 11
- 150000003839 salts Chemical class 0.000 claims description 11
- 159000000000 sodium salts Chemical class 0.000 claims description 11
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 10
- 239000002585 base Substances 0.000 claims description 9
- 239000002054 inoculum Substances 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 150000001447 alkali salts Chemical class 0.000 claims description 8
- 159000000007 calcium salts Chemical class 0.000 claims description 8
- 239000001103 potassium chloride Substances 0.000 claims description 8
- 235000011164 potassium chloride Nutrition 0.000 claims description 8
- 229910017053 inorganic salt Inorganic materials 0.000 claims description 7
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 6
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 6
- 229940024606 amino acid Drugs 0.000 claims description 6
- 235000001014 amino acid Nutrition 0.000 claims description 6
- 150000001413 amino acids Chemical class 0.000 claims description 6
- 235000013619 trace mineral Nutrition 0.000 claims description 6
- 239000011573 trace mineral Substances 0.000 claims description 6
- 229930003779 Vitamin B12 Natural products 0.000 claims description 5
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 claims description 5
- 238000011081 inoculation Methods 0.000 claims description 5
- -1 inorganic acid ammonium salt Chemical class 0.000 claims description 5
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 5
- 235000019163 vitamin B12 Nutrition 0.000 claims description 5
- 239000011715 vitamin B12 Substances 0.000 claims description 5
- 235000019158 vitamin B6 Nutrition 0.000 claims description 5
- 239000011726 vitamin B6 Substances 0.000 claims description 5
- 229940011671 vitamin b6 Drugs 0.000 claims description 5
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 claims description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 4
- 230000004913 activation Effects 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 4
- 229960002989 glutamic acid Drugs 0.000 claims description 4
- 229930182817 methionine Natural products 0.000 claims description 4
- 229910017464 nitrogen compound Inorganic materials 0.000 claims description 4
- 150000002830 nitrogen compounds Chemical class 0.000 claims description 4
- 150000002897 organic nitrogen compounds Chemical group 0.000 claims description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- 235000019270 ammonium chloride Nutrition 0.000 claims description 3
- 235000011089 carbon dioxide Nutrition 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 2
- 239000004475 Arginine Substances 0.000 claims description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 2
- 229930091371 Fructose Natural products 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 2
- XUYPXLNMDZIRQH-LURJTMIESA-N N-acetyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(C)=O XUYPXLNMDZIRQH-LURJTMIESA-N 0.000 claims description 2
- 229910002651 NO3 Inorganic materials 0.000 claims description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims description 2
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 claims description 2
- 239000001888 Peptone Substances 0.000 claims description 2
- 108010080698 Peptones Proteins 0.000 claims description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 2
- 240000000111 Saccharum officinarum Species 0.000 claims description 2
- 235000007201 Saccharum officinarum Nutrition 0.000 claims description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 2
- 239000004473 Threonine Substances 0.000 claims description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 2
- 239000006035 Tryptophane Substances 0.000 claims description 2
- 240000008042 Zea mays Species 0.000 claims description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 2
- VBIXEXWLHSRNKB-UHFFFAOYSA-N ammonium oxalate Chemical compound [NH4+].[NH4+].[O-]C(=O)C([O-])=O VBIXEXWLHSRNKB-UHFFFAOYSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 2
- 235000003704 aspartic acid Nutrition 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 2
- 239000004202 carbamide Substances 0.000 claims description 2
- 125000005586 carbonic acid group Chemical group 0.000 claims description 2
- 235000005822 corn Nutrition 0.000 claims description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 2
- 235000013922 glutamic acid Nutrition 0.000 claims description 2
- 239000004220 glutamic acid Substances 0.000 claims description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 claims description 2
- 229960000310 isoleucine Drugs 0.000 claims description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 2
- 159000000003 magnesium salts Chemical class 0.000 claims description 2
- 235000013379 molasses Nutrition 0.000 claims description 2
- 235000019319 peptone Nutrition 0.000 claims description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 210000000582 semen Anatomy 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 229960004799 tryptophan Drugs 0.000 claims description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 2
- 239000002699 waste material Substances 0.000 claims description 2
- 239000003513 alkali Substances 0.000 abstract description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 4
- 230000002378 acidificating effect Effects 0.000 abstract 3
- 159000000011 group IA salts Chemical class 0.000 abstract 3
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 238000011109 contamination Methods 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 230000001502 supplementing effect Effects 0.000 abstract 1
- 239000000306 component Substances 0.000 description 18
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 15
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 14
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 14
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 13
- DVSZKTAMJJTWFG-UHFFFAOYSA-N docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCCC=CC=CC=CC=CC=CC=CC(O)=O DVSZKTAMJJTWFG-UHFFFAOYSA-N 0.000 description 11
- 230000000050 nutritive effect Effects 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 230000010261 cell growth Effects 0.000 description 8
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 7
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 description 7
- 229910001629 magnesium chloride Inorganic materials 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 238000011169 microbiological contamination Methods 0.000 description 6
- 230000002093 peripheral effect Effects 0.000 description 6
- 235000021323 fish oil Nutrition 0.000 description 5
- 241001467333 Thraustochytriaceae Species 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 3
- 230000033077 cellular process Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000009629 microbiological culture Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 241000199912 Crypthecodinium cohnii Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000003925 brain function Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000009655 industrial fermentation Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000012533 medium component Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000000153 supplemental effect Effects 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 208000003098 Ganglion Cysts Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000195663 Scenedesmus Species 0.000 description 1
- 241000233671 Schizochytrium Species 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 208000005400 Synovial Cyst Diseases 0.000 description 1
- HXWJFEZDFPRLBG-UHFFFAOYSA-N Timnodonic acid Natural products CCCC=CC=CCC=CCC=CCC=CCCCC(O)=O HXWJFEZDFPRLBG-UHFFFAOYSA-N 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000012262 fermentative production Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000007180 physiological regulation Effects 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 235000015598 salt intake Nutrition 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- YODUIMCJDQUOPA-QRPNPIFTSA-M sodium;(2s)-2-amino-3-(4-hydroxyphenyl)propanoate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CC1=CC=C(O)C=C1 YODUIMCJDQUOPA-QRPNPIFTSA-M 0.000 description 1
- WUWHFEHKUQVYLF-UHFFFAOYSA-M sodium;2-aminoacetate Chemical compound [Na+].NCC([O-])=O WUWHFEHKUQVYLF-UHFFFAOYSA-M 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 125000005480 straight-chain fatty acid group Chemical group 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/12—Unicellular algae; Culture media therefor
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Botany (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention discloses a microorganism culture medium and a microorganism culture method. The culture medium comprises a combination of strongly acidic and weakly alkaline salt and weakly acidic and strongly alkaline salt, accordingly has certain pH (potential of hydrogen) control ability, and can control the pH within a constant and suitable range in a culture process, operational steps for supplementing acid and alkali by external equipment to adjust the fermentation pH are reduced or omitted, potential hazards of contamination caused by the operational steps are also reduced or omitted, and the controllability and the stability of a fermentation process are greatly improved. Besides, ammonium salt used as the strongly acidic and weakly alkaline salt can also be used as a nitrogen source to replace parts of yeast extracts, so that consumption of expensive nitrogen sources is reduced, and the cost of the culture medium can be greatly lowered.
Description
Technical field
The invention belongs to microorganism field, relate in particular to a kind of microbiological culture media and cultural method.
Background technology
Polyunsaturated fatty acid (polyunsaturated fatty acids PUFA) refers to contain two or more pairs key, and carbon chain length is the straight chain fatty acid of 16~22 carbon atoms, it is the biomembranous important composition composition of cell and organism, adjustable ganglion cell's configuration, running balance, keep the relatively mobile of cytolemma, to keep the normal physiological function of cell, therefore can affect the chemical constitution of cell, signal transmits, the functions such as immunity, thereby great with being related of relative disease, PUFA has important physiological regulation function in human body, comprise and make the cholesterol esterification, reduce blood cholesterol and triglyceride level, blood viscosity lowering improves blood microcirculation, improve the activity of brain cell, memory and thinking ability etc.Polyunsaturated fatty acid mainly comprises timnodonic acid (EPA), docosahexenoic acid (DHA) etc., DHA has prevention and Cardiovarscular, improve blood viscosity and improve erythrocyte deformability, prevention and treatment cancer, antithrombotic, the effects such as anti-inflammatory, DHA is one of chief component material of human brain, the normal development of baby's brain and the normal performance of adult's brain function there is very important effect, the shortage that studies have shown that DHA can cause brain function to reduce, so expert advice grownup and pregnant woman and the food that need to additional be rich in PUFA, replenish in order to an amount of such as ocean fish etc., DHA is well medicine and nutritive food composition.
In view of critical function and the effect of PUFA, extensively receive the concern of medical profession and food circle at present.The commercial source of tradition preparation PUFA is to separate from fish oil; but from fish oil, extract PUFA and contain strong fishy smell; and resource-constrained; output is unstable; the content of W-3 polyunsaturated fatty acid is because of the kind of fish in the fish oil; the season of fishing for; weather and place different and exist difference; the fish oil output fluctuation is very large; and purifying process is complicated; the product yield is low; some excessive appearance of fishing for behavior of ignoring the possible consequences for commercial benefits that the while product consumption causes greatly; brought disadvantageous effect to environmental resource protection, therefore traditional fish oil preparation method can not satisfy the demand of society.
Found at present to utilize microorganism to produce PUFA; and existing many research reports; particularly utilize the polyunsaturated fatty acids such as algae fermentative Production DHA to become present scholar's study hotspot; the method is not subjected to season; the condition restriction such as region; fatty acid content height and component are single; greatly simplify purifying process and reduced refining difficulty; the culture condition ratio is easier to control; and then for control lipid content and composition provide may; utilize the polyunsaturated fatty acids such as DHA Production by Microorganism Fermentation can also reduce because of the market requirement and fish in a large number the impact on environmental resources that brings, the protection of environmental resources is also had great importance.
The Production by Microorganism Fermentation polyunsaturated fatty acid can be realized culture condition, controls such as the operation of temperature, dissolved oxygen, pH etc., thus controllability and the stability of easier realization culturing process and product quality.The problem that often occurs during the fermentation is, because appearance and/or certain medium component of meta-bolites are consumed, violent fluctuation can appear in pH in the fermentation culture process, under these circumstances, if and in fermentation process, pH is not carried out suitable regulation and control, cellular metabolism speed and upgrowth situation will be affected, even stop growing, therefore, the fermentation culture of microorganism need to be regulated pH.
At present in the achievement in research, microbial fermentation is produced polyunsaturated fatty acid fermenting process pH regulate and control method and is commonly and adopts peripheral equipment supplemental acid alkali lye in the fermentation system to regulate, though this method can be controlled at constant scope with fermentation pH to a certain extent, but also there is some problems, for example increase the fermenting process equipment investment, sterilization process and artificial energy consumption, may bring the hidden danger that other microorganisms cause the fermenting process microbiological contamination into and increased most serious of all, in microbial fermentation is cultivated, in case microbiological contamination will cause tremendous influence and financial loss to the product stably manufactured.
Except adopting peripheral equipment, in the last few years, himself possessed certain pH regulator ability and also become and in the microbial fermentation pH is regulated and control a research direction and effective means by medium component adjustment is made.These methods mainly can be divided into following a few class:
(1) in substratum, adds strong base-weak acid salt.CN101538592B discloses a kind of method of producing docosahexenoic acid with Kou Shi Crypthecodinium cohnii industrial fermentation, and it adds Sodium Glutamate in substratum, do not regulate during the fermentation pH; CN101519676B discloses a kind of method of producing docosahexenoic acid with Kou Shi Crypthecodinium cohnii industrial fermentation, and it adds Sodium Glutamate in substratum, and also replenishes during the fermentation citric acid to regulate pH; CN1218035C discloses a kind of marine microalgae heterotrophism that utilizes and has cultivated the production long chain polyunsaturated fatty acids, and it adds Sodium Glutamate in substratum, do not regulate during the fermentation pH; CN101591617B discloses a kind of docosahexaenoic acid-producing strain and mutagenesis screening method and its application, and it adds Sodium Glutamate and sodium bicarbonate in substratum, do not regulate during the fermentation pH.Nitrogenous source adds in the method for the strong base-weak acid salts such as Sodium Glutamate in these employing substratum, strong base-weak acid salt causes fermenting process pH to occur significantly rising after by cell consumption, and pH can have a strong impact on and change cellular process when too high, and then cause the fermenting process underproduction, and when the needs peripheral equipment replenishes acid solution adjusting pH, not only increase equipment investment, also have simultaneously the microbiological contamination risk.
(2) in substratum, add strong acid weak base salts such as adding inorganic ammonium salt.CN 101528939B discloses and has used the substratum of improvement to produce omega-fatty acid from the thraustochytriale flora, adds during the fermentation sodium hydroxide and regulates pH; CN101812484A discloses a kind of method of producing DHA by Schizochytrium in high-density culture through fermentation, replenishes during the fermentation ammoniacal liquor and regulates pH; A series of patents of the people such as Richard B.Bailey disclose respectively by cultivating the method that eukaryotic microorganisms increases the generation of the lipid that contains polyene fatty acid at the fermentor tank middle-high density, during the fermentation, replenish ammoniacal liquor and regulate pH.Nitrogenous source adds in the method for the strong acid weak base salts such as inorganic ammonium salt in these employing substratum, causes fermenting process pH to occur significantly descending after the strong acid weak base salt consumption.PH crosses when hanging down and will cause fermentation system to become sour, and can have a strong impact on and change cellular process, and then cause the fermenting process underproduction, and strong acid environment is serious to the fermentation equipment infringement simultaneously, is unfavorable for utilizing the extensive and steady in a long-term unsaturated fatty acids of producing of microorganism.If add during the fermentation alkali lye or other high pH solutions are regulated, then increased equipment investment, and had the microbiological contamination risk.
In addition, CN1914327A discloses a kind of method of the THRAUSTOCHYTRIALES of cultivation microorganism belonging to genus, and it adopts in substratum and to add calcium carbonate and regulate and control and stable fermenting process pH.But because the carbonic acid gas that calcium carbonate forms during the fermentation only has limited solubleness in water, thereby cause the during the fermentation reduction of surge capability of this buffer system.
Therefore this area needs new substratum scheme to realize the efficient stable control of pH in the fermenting process.
Summary of the invention
The invention provides a kind of microbiological culture media scheme; fermentation culture process pH raises or the impact of the fluctuation cell growth that descends in order to solve; reduce or eliminate the fermentation culture process and carried out the operation of acid-alkali accommodation by peripheral equipment; and the fermenting process microbiological contamination hidden danger of bringing thus; this substratum scheme is controlled at culturing process pH in the constant scope by the combination of nutritive substance; realize the easy and efficient regulation and control of fermentation culture process pH, significant to the large-scale production of microbial fermentation production unsaturated fatty acids.
For reaching this purpose, the present invention by the following technical solutions:
In first aspect, the invention provides a kind of substratum, comprise the combination of strong acid weak base salt and weak acid strong alkali salt in the described substratum to control during the fermentation pH, wherein, described strong acid weak base salt is organic and the inorganic acid ammonium salt, is preferably ammonium nitrate or ammonium sulfate, ammonium chloride, ammonium oxalate more preferably is ammonium sulfate, and described weak acid strong alkali salt is carbonic acid or amino acid whose sodium salt, sylvite or calcium salt.
In substratum of the present invention, the combination of described strong acid weak base salt and weak acid strong alkali salt can be used for the pH of described substratum is controlled to be 4.0-9.0, preferably 5.0-8.0, most preferably 6.0-7.0.
In substratum of the present invention, described amino acid whose sodium salt, sylvite or calcium salt can be sodium salt, sylvite or calcium salt or its mixtures of at least 2 kinds of L-glutamic acid, aspartic acid, Methionin, arginine, Histidine, glycine, Serine, Threonine, halfcystine, tyrosine, L-Ala, α-amino-isovaleric acid, leucine, Isoleucine, proline(Pro), phenylalanine, tryptophane or methionine(Met).
In substratum of the present invention, described weak acid strong alkali salt can be Sodium Glutamate.
In substratum of the present invention, the content of Sodium Glutamate can be 1-20g/L, is preferably 5-15g/L, and more preferably 8-12g/L most preferably is 10g/L.
In substratum of the present invention, the content of ammonium sulfate can be 0.5-5g/L, is preferably 1-4g/L, and more preferably 2-3.5g/L most preferably is 3g/L.
Substratum of the present invention can also comprise other nitrogenous sources, carbon source, inorganic salt and trace element;
Preferably, described carbon source is waste molasses, sugar cane juice, Semen Maydis powder, sucrose, fructose, glucose, Zulkovsky starch, carbonic acid gas or its mixture of at least 2 kinds;
Preferably, described nitrogenous source is organic nitrogen compound, inorganic nitrogen compound or its mixture;
Preferably, described inorganic salt comprise sodium salt, magnesium salts, sylvite, molysite, calcium salt, vitriol, carbonate, supercarbonate, acetate or its mixture of at least 2 kinds; And/or,
Preferably, described trace element comprises VITMAIN B1, vitamin B6, vitamin B12, vitamin H, 6-benzyl aminoadenine (6-BA) or its mixture of at least 2 kinds.
In substratum of the present invention, described organic nitrogen compound comprises yeast extract, yeast extract paste, corn steep liquor, peptone, amino acid, Sodium Glutamate or its mixture of at least 2 kinds.
In substratum of the present invention, described inorganic nitrogen compound comprises urea, nitrite, nitrate, inorganic ammonium salt or its mixture of at least 2 kinds.
Substratum of the present invention can comprise: glucose 10-200g/L, Sodium Glutamate 1-20g/L, ammonium sulfate 0.5-5g/L, yeast extract paste concentration is the 1/2-1/10 of carbon source concentration, 5-20g/L preferably, described inorganic salt are take sodium salt as standard, 0.1-35g/L, VITMAIN B1 concentration 10-30ppm in the described trace element, vitamin B6 concentration 5-15ppm, vitamin B12 concentration 1-5ppm, vitamin H concentration 1-5ppm, 6-BA concentration 3-15ppm.
The pH of substratum of the present invention can be 4.0,4.5,5.0,5.5,6.0,6.5,7.0,7.5,8.0,8.5 or 9.0.
Substratum Glutamic Acid sodium content of the present invention can be 1g/L, 2g/L, 3g/L, 4g/L, 5g/L, 6g/L, 7g/L, 8g/L, 9g/L, 10g/L, 11g/L, 12g/L, 13g/L, 14g/L, 15g/L, 16g/L, 17g/L, 18g/L, 19g/L or 20g/L.
The content of ammonium sulfate can be 0.5g/L, 1.0g/L, 1.5g/L, 2.0g/L, 2.5g/L, 3.0g/L, 3.5g/L, 4.0g/L, 4.5g/L or 5.0g/L in the substratum of the present invention.
The content of glucose can be 10g/L, 20g/L, 30g/L, 40g/L, 50g/L, 60g/L, 70g/L, 80g/L, 90g/L, 100g/L, 110g/L, 120g/L, 130g/L, 140g/L, 150g/L, 160g/L, 170g/L, 180g/L, 190g/L or 200g/L in the substratum of the present invention.
The content of yeast extract paste can be 1g/L, 5g/L, 10g/L, 15g/L, 20g/L, 25g/L, 30g/L, 35g/L, 40g/L, 45g/L, 50g/L, 55g/L, 60g/L, 65g/L, 70g/L, 75g/L, 80g/L, 85g/L, 90g/L, 95g/L or 100g/L in the substratum of the present invention.
The content of inorganic salt in the substratum of the present invention (take sodium salt as standard) can be 0.1g/L, 0.5g/L, 1g/L, 5g/L, 10g/L, 15g/L, 20g/L, 25g/L, 30g/L or 35g/L.
The concentration of VITMAIN B1 can be 10ppm, 15ppm, 20ppm, 25ppm or 30ppm in the substratum of the present invention.
The concentration of vitamin B6 can be 5ppm, 8ppm, 10ppm, 12ppm or 15ppm in the substratum of the present invention.
The concentration of vitamin B12 can be 1ppm, 2ppm, 3ppm, 4ppm or 5ppm in the substratum of the present invention.
The concentration of vitamin H can be 1ppm, 2ppm, 3ppm, 4ppm or 5ppm in the substratum of the present invention.
The concentration of VITAMIN 6-BA can be 3ppm, 6ppm, 9ppm, 12ppm or 15ppm in the substratum of the present invention.
In yet another aspect, the invention provides a kind ofly at method for culturing microbes, described method comprises during the fermentation and to adopt such as the described substratum of first aspect.
In cultural method of the present invention, described microorganism is little algae.
Cultural method of the present invention can be included in shaking flask preculture, first order seed cultivation, secondary seed cultivation and/or the three grade fermemtation cultivation and adopt the described substratum of first aspect.
Cultural method of the present invention can comprise:
A) activation culture adopts inclined-plane or plate streaking with the algae kind, and in 25 ℃ of constant temperature culture 3-5 days, full, the eugonic algae of picking form fell, and again carries out inclined-plane or plate streaking, in 25 ℃ of constant temperature culture 3-5 days;
B) shaking flask preculture, the algae of picking activation falls to being inoculated in the clean shaking flask, and 25 ℃, 150-300rpm, preferred 150-250rpm, most preferably shaking culture under the 200rpm;
C) fermentation amplification culture, the algae kind access first class seed pot that wherein the shaking flask preculture is obtained, inoculum size 2%-10%, preferred 4%-8%, most preferably 6%, pass into sterile air and stir, air flow 0.4-1.0vvm, preferred 0.5-0.8vvm, most preferably 0.7vvm, stirring velocity 100-300rpm, preferred 150-250rpm, most preferably 200rpm, the control culture temperature is at 24-28 ℃, preferred 25-27 ℃, most preferably 26 ℃, carry out first order seed and cultivate; Fermentation seed liquid in the first class seed pot is seeded to the secondary seed tank, inoculum size 5%-15%, preferred 7%-13%, most preferably 10%, pass into sterile air and stir air flow 0.4-1.0vvm, preferred 0.5-0.8vvm, 0.7vvm most preferably, stirring velocity 100-300rpm, preferred 150-250rpm, most preferably 200rpm controls culture temperature at 24-28 ℃, preferred 25-27 ℃, most preferably 25 ℃, carry out secondary seed and cultivate; Will be in the secondary seed tank carry out fermentation culture in the fermentation seed liquid inoculation three grade fermemtation tank, the preferred 7%-13% of inoculum size, most preferably 10%, lead to continuously in the process and add sterile air, air flow 0.4-1.0vvm, air flow 0.4-1.0vvm, preferred 0.5-0.8vvm, 0.7vvm most preferably, stirring velocity 100-200rpm, preferred 120-180rpm, most preferably 150rpm controls culture temperature at 24-28 ℃, preferred 25-27 ℃, most preferably 26 ℃, carry out fermentation culture;
Wherein step b) and c) in the substratum that adopts be such as the described substratum of first aspect.Beneficial effect of the present invention:
(1) the present invention forms design by fermention medium, adopt the nutritive ingredient combination to come efficient controlled fermentation process pH fluctuation, make pH be controlled at constant and optimum range in, reduce or reduced by peripheral equipment and replenished the operation steps that soda acid is regulated fermentation pH, and the microbiological contamination hidden danger of bringing thus, greatly improve fermenting process controllability and stability;
(2) ammonium salt of method employing of the present invention can be used as nitrogenous source Substitute For Partial yeast extract paste, realizes the decrement of high price nitrogenous source, can greatly reduce culture medium cost.
Description of drawings
Fig. 1 is the schematic flow sheet of cultural method of the present invention.
Embodiment
Further specify technical scheme of the present invention below by embodiment.
Embodiment 1
Adopt substratum of the present invention (concrete composition sees Table 1), carry out the 500L of algae kind, 6 cubes, 60 cubes three grades of amplification culture according to the following step, algae kind Yu Haiyang thraustochytriale (Thraustochytrids) class:
At first, the algae kind is activated, adopt inclined-plane or plate streaking, in 25 ℃ of constant temperature culture 3-5 days, full, the eugonic algae of picking form fell, and again carries out inclined-plane or plate streaking, as shaking flask preculture algae kind, store method adopts cryogenic freezing after 25 ℃ of constant temperature culture 3-5 days.
Secondly, the shaking flask preculture, the picking algae falls to being inoculated in to contain in the clean shaking flask of aseptic above-mentioned substratum, 25 ℃, shaking culture under the 150-300rpm, this step can comprise that 2-3 level volume amplifies preculture, finish seed pre-culture after, shake-flask seed is incorporated in the sterile chamber, and this step is the seed pre-culture stage.
The fermentation amplification culture again, comprise one-level, secondary and three grades of amplification fermentation culture, flame differential pressure inoculation method access first class seed pot is adopted in the shake-flask seed inoculation, inoculum size 2%-10% passes into sterile air and stirs air flow 0.4-1.0vvm, 100-300rpm, the control culture temperature optimum 25 ℃, is carried out first order seed and is cultivated at 24-28 ℃.First order seed adopts pressure differential method to be seeded to the secondary seed tank that contains above-mentioned aseptic culture medium fermentation seed liquid in the first class seed pot after being cultured to certain phase, inoculum size 5%-15%, after the secondary seed tank is finished inoculation, pass into sterile air and stirring, air flow 0.4-1.0vvm, 100-300rpm, the control culture temperature is at 24-28 ℃, optimum 25 ℃, carry out secondary seed and cultivate.Secondary seed is cultured to and adopts pressure differential method to be seeded in the three grade fermemtation tank that contains above-mentioned aseptic culture medium fermentation seed liquid in the secondary seed tank behind the certain phase to carry out fermentation culture, inoculum size 5-15%, lead to continuously in the process and add sterile air, air flow 0.4-1.0vvm, 100-200rpm, the control culture temperature optimum 25 ℃, is carried out fermentation culture at 24-28 ℃.
At last, when dry cell weight increases to plateau or cell and is not suitable for continuing the situation such as cultivation and occurs, stop fermentation culture, put tank, fermented liquid is stored in the storage tank, pass into whizzer and carry out the concentrated collection of fermented liquid, after obtaining concentrated solution, pass into and obtain product in the spray-drying tower.
The two is consumed in cellular process, and pH produces the impact that raises and reduce on fermentation, and effect is cancelled out each other, and realizes the stable and efficient control of fermenting process pH.
Table 1: substratum forms
Component | Content (g/L) | Component | Content (ppm) |
Glucose | 30 | VITMAIN B1 | 30 |
Yeast extract paste | 15 | B6 | 5 |
Sodium Glutamate | 1 | B12 | 1 |
Ammonium sulfate | 0.5 | Vitamin H | 1 |
Sodium-chlor | 12 | 6-BA | 3 |
Sal epsom | 3 | ||
Magnesium chloride | 3 | ||
Repone K | 1 | ||
Calcium sulfate | 1 |
Detect dry cell weight, sugared concentration, pH, amino nitrogen in the fermenting process, add the nutritive elements such as carbon source, nitrogenous source according to the Growth of Cells situation, when carbon source concentration is lower than 1%, add 50% sugar soln to fermented liquid sugar concentration 1.5-2%.Fermenting process does not need to adopt the extra supplemental acid alkali lye of peripheral equipment to regulate pH, and the pH of substratum is basicly stable in 5.0-7.0 in the fermenting process after testing, belongs to the suitable pH of the cultivation scope of marine alga.
Embodiment 2
Adopt substratum of the present invention (concrete composition see Table 2), adopt with embodiment 1 in identical algae kind and method 500L, 6 cubes, 60 cubes three grades of amplification culture of carrying out the algae kind:
Table 2: substratum forms
Component | Content (g/L) | Component | Content (ppm) |
Glucose | 80 | VITMAIN B1 | 10 |
Yeast extract paste | 30 | B6 | 15 |
Sodium Glutamate | 15 | B12 | 5 |
Ammonium nitrate | 4 | Vitamin H | 5 |
Sodium-chlor | 5 | 6-BA | 3 |
Sal epsom | 1 | ||
Magnesium chloride | 1 | ||
Repone K | 1 | ||
Calcium sulfate | 1 |
With similar among the embodiment 1, detect during the fermentation dry cell weight, sugared concentration, pH, amino nitrogen, add the nutritive elements such as carbon source, nitrogenous source according to the Growth of Cells situation.The pH of substratum is basicly stable in 5.5-6.8 in the fermenting process after testing, belongs to the suitable pH of the cultivation scope of marine alga.
Embodiment 3
Adopt substratum of the present invention (concrete composition see Table 3), adopt with embodiment 1 in identical algae kind and method 500L, 6 cubes, 60 cubes three grades of amplification culture of carrying out the algae kind:
Table 3: substratum forms
Component | Content (g/L) | Component | Content (ppm) |
Glucose | 100 | VITMAIN B1 | 10 |
Yeast extract paste | 40 | B6 | 15 |
Sodium Glutamate | 20 | B12 | 5 |
Ammonium chloride | 3 | Vitamin H | 5 |
Sodium-chlor | 5 | 6-BA | 3 |
Sal epsom | 1 | ||
Magnesium chloride | 1 | ||
Repone K | 0.5 | ||
Calcium sulfate | 0.1 |
With similar among the embodiment 1, detect during the fermentation dry cell weight, sugared concentration, pH, amino nitrogen, add the nutritive elements such as carbon source, nitrogenous source according to the Growth of Cells situation.The pH of substratum is basicly stable in 4.5-6.0 in the fermenting process after testing, belongs to the suitable pH of the cultivation scope of marine alga.
Embodiment 4
Adopt substratum of the present invention (concrete composition see Table 4), adopt with embodiment 1 in identical algae kind and method 500L, 6 cubes, 60 cubes three grades of amplification culture of carrying out the algae kind:
Table 4: substratum forms
Component | Content (g/L) | Component | Content (ppm) |
Glucose | 200 | VITMAIN B1 | 10 |
Yeast extract paste | 100 | B6 | 15 |
Salt of wormwood | 20 | B12 | 5 |
Ammonium nitrate | 5 | Vitamin H | 5 |
Sodium-chlor | 12 | 6-BA | 3 |
Sal epsom | 1 | ||
Magnesium chloride | 1 | ||
Repone K | 1 | ||
Calcium sulfate | 1 |
With similar among the embodiment 1, detect during the fermentation dry cell weight, sugared concentration, pH, amino nitrogen, add the nutritive elements such as carbon source, nitrogenous source according to the Growth of Cells situation.The pH of substratum is basicly stable in 5.3-6.5 in the fermenting process after testing, belongs to the suitable pH of the cultivation scope of marine alga.
Embodiment 5
Adopt substratum of the present invention (concrete composition sees Table 5), adopt grid algaes (Scenedesmus sp.) algae kind to carry out 500L, 6 cubes, 60 cubes three grades of amplification culture:
Table 5: substratum forms
Component | Content (g/L) | Component | Content (ppm) |
Glucose | 60 | VITMAIN B1 | 20 |
Yeast extract paste | 20 | B6 | 15 |
Sodium glycocollate | 10 | B12 | 5 |
Ammonium sulfate | 3.5 | Vitamin H | 5 |
Sodium-chlor | 5 | 6-BA | 3 |
Sal epsom | 1 | ||
Magnesium chloride | 1 | ||
Repone K | 1 | ||
Calcium sulfate | 1 |
With similar among the embodiment 1, detect during the fermentation dry cell weight, sugared concentration, pH, amino nitrogen, add the nutritive elements such as carbon source, nitrogenous source according to the Growth of Cells situation.The pH of substratum is basicly stable in 6.5-8.2 in the fermenting process after testing, belongs to the suitable pH of the cultivation scope of marine alga.
Embodiment 6
Adopt substratum of the present invention (concrete composition see Table 6), adopt with embodiment 5 in identical algae kind carry out 500L, 6 cubes, 60 cubes three grades of amplification culture:
Table 6: substratum forms
Component | Content (g/L) | Component | Content (ppm) |
Glucose | 150 | VITMAIN B1 | 20 |
Yeast extract paste | 70 | B6 | 15 |
Sodium histidinate | 5 | B12 | 5 |
Ammonium sulfate | 4.5 | Vitamin H | 5 |
Sodium-chlor | 5 | 6-BA | 3 |
Sal epsom | 1 | ||
Magnesium chloride | 1 | ||
Repone K | 1 |
Calcium sulfate | 1 |
With similar among the embodiment 1, detect during the fermentation dry cell weight, sugared concentration, pH, amino nitrogen, add the nutritive elements such as carbon source, nitrogenous source according to the Growth of Cells situation.The pH of substratum is basicly stable in 7.8-9.0 in the fermenting process after testing, belongs to the suitable pH of the cultivation scope of marine alga.
Embodiment 7
Adopt substratum of the present invention (concrete composition see Table 7), adopt with embodiment 5 in identical algae kind carry out 500L, 6 cubes, 60 cubes three grades of amplification culture:
Table 7: substratum forms
Component | Content (g/L) | Component | Content (ppm) |
Glucose | 10 | VITMAIN B1 | 20 |
Yeast extract paste | 5 | B6 | 15 |
Sodium L-tyrosinate | 10 | B12 | 5 |
Ammonium sulfate | 3.5 | Vitamin H | 5 |
Sodium-chlor | 5 | 6-BA | 3 |
Sal epsom | 1 | ||
Magnesium chloride | 1 | ||
Repone K | 1 | ||
Calcium sulfate | 1 |
With similar among the embodiment 1, detect during the fermentation dry cell weight, sugared concentration, pH, amino nitrogen, add the nutritive elements such as carbon source, nitrogenous source according to the Growth of Cells situation.The pH of substratum is basicly stable in 6.8-8.3 in the fermenting process after testing, belongs to the suitable pH of the cultivation scope of marine alga.
Applicant's statement, the present invention illustrates detailed features of the present invention and method by above-described embodiment, but the present invention is not limited to above-mentioned detailed features and method, does not mean that namely the present invention must rely on above-mentioned detailed features and method could be implemented.The person of ordinary skill in the field should understand, any improvement in the present invention to the increase of the equivalence replacement of the selected component of the present invention and auxiliary component, the selection of concrete mode etc., all drops within protection scope of the present invention and the open scope.
Claims (13)
1. substratum, comprise the combination of strong acid weak base salt and weak acid strong alkali salt in the described substratum, wherein, described strong acid weak base salt is organic and the inorganic acid ammonium salt, be preferably ammonium nitrate, ammonium sulfate, ammonium chloride, ammonium oxalate or at least two kinds mixture wherein more preferably are ammonium sulfate, and described weak acid strong alkali salt is carbonic acid or amino acid whose sodium salt, sylvite or calcium salt or at least two kinds mixture wherein.
2. substratum according to claim 1 is characterized in that, the combination of described strong acid weak base salt and weak acid strong alkali salt is controlled to be 4.0-9.0 with the pH of described substratum, preferably 5.0-8.0, most preferably 6.0-7.0.
3. substratum according to claim 1 and 2, it is characterized in that described amino acid whose sodium salt, sylvite or calcium salt are sodium salt, sylvite or calcium salt or its mixture of at least 2 kinds of L-glutamic acid, aspartic acid, Methionin, arginine, Histidine, glycine, Serine, Threonine, halfcystine, tyrosine, L-Ala, α-amino-isovaleric acid, leucine, Isoleucine, proline(Pro), phenylalanine, tryptophane or methionine(Met).
4. substratum according to claim 1 and 2 is characterized in that, described weak acid strong alkali salt is Sodium Glutamate.
5. substratum according to claim 4 is characterized in that, the content of described substratum Glutamic Acid sodium is 1-20g/L, is preferably 5-15g/L, and more preferably 8-12g/L most preferably is 10g/L.
6. each described substratum is characterized in that according to claim 1-5, and the content of ammonium sulfate is 0.5-5g/L, is preferably 1-4g/L, and more preferably 2-3.5g/L most preferably is 3g/L.
7. each described substratum is characterized in that according to claim 1-6, also comprises other nitrogenous sources, carbon source, inorganic salt and trace element in the described substratum;
Preferably, described carbon source is waste molasses, sugar cane juice, Semen Maydis powder, sucrose, fructose, glucose, Zulkovsky starch, carbonic acid gas or its mixture of at least 2 kinds;
Preferably, described nitrogenous source is organic nitrogen compound, inorganic nitrogen compound or its mixture;
Preferably, described inorganic salt comprise sodium salt, magnesium salts, sylvite, molysite, calcium salt, vitriol, carbonate, supercarbonate, acetate or its mixture of at least 2 kinds; And/or,
Preferably, described trace element comprises VITMAIN B1, vitamin B6, vitamin B12, vitamin H, 6-benzyl aminoadenine (6-BA) or its mixture of at least 2 kinds.
8. substratum according to claim 7 is characterized in that, described organic nitrogen compound comprises yeast extract, yeast extract paste, corn steep liquor, peptone, amino acid, Sodium Glutamate or its mixture of at least 2 kinds; And/or,
Described inorganic nitrogen compound comprises urea, nitrite, nitrate, inorganic ammonium salt or its mixture of at least 2 kinds.
9. substratum according to claim 1 is characterized in that described substratum comprises: glucose 10-200g/L, Sodium Glutamate 1-20g/L, ammonium sulfate 0.5-5g/L, yeast extract paste concentration is the 1/2-1/10 of carbon source concentration, and described inorganic salt are take sodium salt as standard, 0.1-35g/L, VITMAIN B1 concentration 10-30ppm in the described trace element, vitamin B6 concentration 5-15ppm, vitamin B12 concentration 1-5ppm, vitamin H concentration 1-5ppm, 6-BA concentration 3-15ppm.
10. a method for culturing microbes is characterized in that, described method comprises that employing is such as each described substratum among the claim 1-9 during the fermentation.
11. method as claimed in claim 10 is characterized in that, described microorganism is little algae.
12., it is characterized in that described method is included in shaking flask preculture, first order seed cultivation, secondary seed cultivation and/or the three grade fermemtation cultivation and adopts such as each described substratum among the claim 1-9 such as claim 10 or 11 described methods.
13. method as claimed in claim 12, described method comprises:
A) activation culture adopts inclined-plane or plate streaking with the algae kind, and in 25 ℃ of constant temperature culture 3-5 days, full, the eugonic algae of picking form fell, and again carries out inclined-plane or plate streaking, in 25 ℃ of constant temperature culture 3-5 days;
B) shaking flask preculture, the algae of picking activation falls to being inoculated in the clean shaking flask, and 25 ℃, 150-300rpm, preferred 150-250rpm, most preferably shaking culture under the 200rpm;
C) fermentation amplification culture, the algae kind access first class seed pot that wherein the shaking flask preculture is obtained, inoculum size 2%-10%, preferred 4%-8%, most preferably 6%, pass into sterile air and stir, air flow 0.4-1.0vvm, preferred 0.5-0.8vvm, most preferably 0.7vvm, stirring velocity 100-300rpm, preferred 150-250rpm, most preferably 200rpm, the control culture temperature is at 24-28 ℃, preferred 25-27 ℃, most preferably 26 ℃, carry out first order seed and cultivate; Fermentation seed liquid in the first class seed pot is seeded to the secondary seed tank, inoculum size 5%-15%, preferred 7%-13%, most preferably 10%, pass into sterile air and stir air flow 0.4-1.0vvm, preferred 0.5-0.8vvm, 0.7vvm most preferably, stirring velocity 100-300rpm, preferred 150-250rpm, most preferably 200rpm controls culture temperature at 24-28 ℃, preferred 25-27 ℃, most preferably 25 ℃, carry out secondary seed and cultivate; Will be in the secondary seed tank carry out fermentation culture in the fermentation seed liquid inoculation three grade fermemtation tank, the preferred 7%-13% of inoculum size, most preferably 10%, lead to continuously in the process and add sterile air, air flow 0.4-1.0vvm, air flow 0.4-1.0vvm, preferred 0.5-0.8vvm, 0.7vvm most preferably, stirring velocity 100-200rpm, preferred 120-180rpm, most preferably 150rpm controls culture temperature at 24-28 ℃, preferred 25-27 ℃, most preferably 26 ℃, carry out fermentation culture;
Wherein step b) and c) in the substratum that adopts be such as each described substratum among the claim 1-9.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210369787.XA CN102911868B (en) | 2012-09-28 | 2012-09-28 | A kind of microbiological culture media and cultural method |
US14/041,473 US9434967B2 (en) | 2012-09-28 | 2013-09-30 | Microbial culture medium and cultural method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210369787.XA CN102911868B (en) | 2012-09-28 | 2012-09-28 | A kind of microbiological culture media and cultural method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102911868A true CN102911868A (en) | 2013-02-06 |
CN102911868B CN102911868B (en) | 2015-12-09 |
Family
ID=47610450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210369787.XA Active CN102911868B (en) | 2012-09-28 | 2012-09-28 | A kind of microbiological culture media and cultural method |
Country Status (2)
Country | Link |
---|---|
US (1) | US9434967B2 (en) |
CN (1) | CN102911868B (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105199993A (en) * | 2015-10-22 | 2015-12-30 | 中国人民大学 | Photosynthetic bacteria culture medium and preparation method thereof |
CN106509479A (en) * | 2016-09-30 | 2017-03-22 | 防城港市金沙海洋科技有限责任公司 | Special alga culturing fertilizer for aquaculture |
CN107056513A (en) * | 2017-06-27 | 2017-08-18 | 山东昆仲知识产权代理有限公司 | Microbial bacteria agent and process for producing same |
CN115651874A (en) * | 2022-11-21 | 2023-01-31 | 清华大学 | Culture medium and culture method for culturing halophilic microorganisms |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018112177A1 (en) | 2016-12-14 | 2018-06-21 | Heliae Development, Llc | Phytohormone enriched microalgae methods and compositions |
CN108641996B (en) * | 2018-06-19 | 2020-12-01 | 广东容大生物股份有限公司 | Fermentation medium of bacillus licheniformis and production method thereof |
CN108796004A (en) * | 2018-06-20 | 2018-11-13 | 齐齐哈尔龙江阜丰生物科技有限公司 | A kind of technique of preparing lysine through fermentation |
CN112143661A (en) * | 2020-10-13 | 2020-12-29 | 苏州吉态来胺生物科技有限公司 | Method for producing microbial peptone by using vegetable oil as raw material |
CN113218723A (en) * | 2021-03-16 | 2021-08-06 | 吴敏 | Composition for microscopic observation and preparation method and application thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1358839A (en) * | 2000-12-11 | 2002-07-17 | 姜悦 | Culture of long chain unsaturated fatty acid by heterotrophic marine microalgal |
CN1914327A (en) * | 2003-11-10 | 2007-02-14 | 努特诺瓦营养产品及食品成分有限公司 | Process for the cultivation of microorganisms of the genus thraustochytriales |
CN1986822A (en) * | 2006-12-15 | 2007-06-27 | 湖北友芝友生物科技有限公司 | Crypthecodinium connii fermenting process for producing docosahexaenoic acid grease |
CN101037658A (en) * | 2006-04-29 | 2007-09-19 | 浙江工业大学 | Bacillus subtilis ZJB-063 and its application |
CN101519676A (en) * | 2009-04-03 | 2009-09-02 | 湖北福星生物科技有限公司 | Method for producing docosahexenoic acid by fermenting schizochytrium |
CN101538592A (en) * | 2009-04-28 | 2009-09-23 | 湖北福星生物科技有限公司 | Method for producing DHA by Crypthecodinium cohnii industrial fermentation |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69528440T2 (en) * | 1994-12-20 | 2003-06-18 | Cosmo Oil Co. Ltd., Tokio/Tokyo | 5-aminolevulinic acid producing microorganism |
ATE556144T1 (en) | 2006-10-27 | 2012-05-15 | Lonza Ag | PRODUCTION OF OMEGA-3 FATTY ACIDS IN THE MICROFLORA OF THRAUSTOCHYTRIALES USING MODIFIED MEDIA |
CN101812484B (en) | 2009-03-20 | 2012-04-25 | 厦门汇盛生物有限公司 | Method for producing DHA by Schizochytrium in high-density culture through fermentation |
US20120034698A1 (en) * | 2009-04-02 | 2012-02-09 | Rosetta Green Ltd. | Compositions and methods for increasing oil content in algae |
CN101591617B (en) | 2009-06-15 | 2011-03-23 | 南京工业大学 | Docosahexaenoic acid producing strain, mutation screening method and application thereof |
-
2012
- 2012-09-28 CN CN201210369787.XA patent/CN102911868B/en active Active
-
2013
- 2013-09-30 US US14/041,473 patent/US9434967B2/en not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1358839A (en) * | 2000-12-11 | 2002-07-17 | 姜悦 | Culture of long chain unsaturated fatty acid by heterotrophic marine microalgal |
CN1914327A (en) * | 2003-11-10 | 2007-02-14 | 努特诺瓦营养产品及食品成分有限公司 | Process for the cultivation of microorganisms of the genus thraustochytriales |
CN101037658A (en) * | 2006-04-29 | 2007-09-19 | 浙江工业大学 | Bacillus subtilis ZJB-063 and its application |
CN1986822A (en) * | 2006-12-15 | 2007-06-27 | 湖北友芝友生物科技有限公司 | Crypthecodinium connii fermenting process for producing docosahexaenoic acid grease |
CN101519676A (en) * | 2009-04-03 | 2009-09-02 | 湖北福星生物科技有限公司 | Method for producing docosahexenoic acid by fermenting schizochytrium |
CN101538592A (en) * | 2009-04-28 | 2009-09-23 | 湖北福星生物科技有限公司 | Method for producing DHA by Crypthecodinium cohnii industrial fermentation |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105199993A (en) * | 2015-10-22 | 2015-12-30 | 中国人民大学 | Photosynthetic bacteria culture medium and preparation method thereof |
CN106509479A (en) * | 2016-09-30 | 2017-03-22 | 防城港市金沙海洋科技有限责任公司 | Special alga culturing fertilizer for aquaculture |
CN107056513A (en) * | 2017-06-27 | 2017-08-18 | 山东昆仲知识产权代理有限公司 | Microbial bacteria agent and process for producing same |
CN115651874A (en) * | 2022-11-21 | 2023-01-31 | 清华大学 | Culture medium and culture method for culturing halophilic microorganisms |
Also Published As
Publication number | Publication date |
---|---|
CN102911868B (en) | 2015-12-09 |
US20140093922A1 (en) | 2014-04-03 |
US9434967B2 (en) | 2016-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102911868B (en) | A kind of microbiological culture media and cultural method | |
CN101519676B (en) | Method for producing docosahexenoic acid by fermenting schizochytrium | |
CN103146584B (en) | Liquid fermentation production method of docosahexenoic acid (DHA) through solid material cultivation of schizochytrium sp. | |
CN102174449B (en) | Method for producing high-yield gamma-propalanine and application thereof | |
CN105018539B (en) | A method of culture schizochytrium limacinum high yield DHA | |
CN102168115A (en) | Industrialized production method of coenzyme Q10 | |
CN102864111B (en) | Schizochytrium limacinum strain for producing docosahexaenoic acid | |
KR20220088912A (en) | Schizochytrium and its application, Sn-2 DHA-rich microorganism maintenance and its manufacturing method and application | |
CN109797104A (en) | A kind of chlorella Chlorella zofingiensis heterotrophism high-density cultivation method | |
CN107164238B (en) | Schizochytrium limacinum strain and mutagenesis method and application thereof | |
CN102925503B (en) | Method for preparing ARA (Arachidonic Acid) by culturing mortierella alpina by utilizing solid material culture medium | |
CN110195019A (en) | A kind of cultural method of High yield proteid chlorella | |
CN102286564A (en) | Method for culturing halophilic microorganism to produce ectoin and hydroxyl ectoin | |
CN102559552A (en) | Production method and application of high-yield gamma-aminobutyric acid | |
US20130217085A1 (en) | Methods for improving fermentation yield of polyunsaturated fatty acids | |
CN101591617B (en) | Docosahexaenoic acid producing strain, mutation screening method and application thereof | |
CN103642694A (en) | High-yield cultivation method of botryococcus | |
CN105132485B (en) | A kind of method of schizochytrium limacinum fermentation production DHA | |
KR101159869B1 (en) | Process for cultivating microorganisms of the genus Thraustochytriales | |
CN101709297A (en) | Mutagenesis screening method of arachidonic acid producing strain mortierella alpina | |
CN101538592A (en) | Method for producing DHA by Crypthecodinium cohnii industrial fermentation | |
CN1358839A (en) | Culture of long chain unsaturated fatty acid by heterotrophic marine microalgal | |
CN114058514B (en) | Method for accumulating starch by using marine green alga Phaeophyllum glaucum | |
CN103088081B (en) | Biotin supplemented fermentation method for producing glutamic acid | |
CN109258305A (en) | A kind of method for promoting sclerotium of morchella esculenta to be formed and its fluid nutrient medium used |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |